Isodiol International Inc. Stock

ISOLF

CA46500L2003

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 22:05:45 10/07/2026 +03			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-

09/10/19	Isodiol International Inc. Enters into Strategic Relationship with Vitamin Shoppe Inc	CI
20/12/18	Isodiol International Inc. Appoints Michael Cancelleri as Chief Executive Officer and Chairman of the Board of Directors	CI

Valuation: Isodiol International Inc.

Market Cap	3.91M 2.81M 2.43M 2.27M 2.08M 267M 3.97M 26.6M 10.44M 134M 10.54M 10.31M 443M	P/E 2018	-4.94x	P/E 2019	-0.37x
Enterprise Value	9.13M 6.55M 5.67M 5.29M 4.86M 624M 9.28M 62.11M 24.38M 313M 24.61M 24.07M 1.03B	EV / Sales 2018	12.6x	EV / Sales 2019	2.48x
Free-Float	100%	Yield 2018 *	-	Yield 2019	-

* Estimated data More valuation ratios

Chart: Isodiol International Inc.

Dynamic Chart

Latest news : Isodiol International Inc.

09/10/19	Isodiol International Inc. Enters into Strategic Relationship with Vitamin Shoppe Inc	CI
20/12/18	Isodiol International Inc. Appoints Michael Cancelleri as Chief Executive Officer and Chairman of the Board of Directors	CI
30/05/18	Liberty Health Sciences Inc. Signs Licensing Agreement with Isodiol International Inc. to Provide A Complementary Suite of Medical Cannabis Products to Patients in Florida and Massachusetts	CI
24/05/18	Sundial Announces Letter of Intent for the Supply of 99.5%+ CBD Isolate from Isodiol International	CI
07/05/18	Scythian Biosciences Corp. Signs an Agreement with Isodiol International Inc. to Import and Distribute Isodiol Products	CI
07/05/18	Isodiol International Inc. announced that it has received CAD 2 million in funding from Scythian Biosciences Corp.	CI
27/12/17	Isodiol International Inc. announced that it has received CAD 30.1 million in funding from Serruya Private Equity, Scythian Biosciences Corp., Liberty Health Sciences Inc.	CI
01/11/17	Nutritional High International Inc. and Isodiol International Inc. Announce Distribution Relationship	CI
20/07/17	Isodiol International Inc. Signs Definitive Licensing Agreement with Canopy Growth Corporation for Canadian and International Distribution	CI

More news

Managers and Directors: Isodiol International Inc.

Manager	Title	Age	Since
Marcos Agramont CEO	Chief Executive Officer	-	24/05/2017
Andrew Alvis DFI	Director of Finance/CFO	-	-
Marvin Washington PRN	Corporate Officer/Principal	-	30/08/2018

Director	Title	Age	Since
Marcos Agramont BRD	Director/Board Member	-	24/05/2017
Marvin Washington BRD	Director/Board Member	-	30/08/2018
Leonardo Matesanz BRD	Director/Board Member	-	21/11/2018

More insiders

Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
ISOLF Stock

As early as today, start finding the best investment opportunities!

Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.29
10 years	0		16.9

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ISODIOL INTERNATIONAL INC.	-.--%	-.--%	-	-	128
YUNNAN BAIYAO GROUP CO.,LTD	+0.14%	-3.97%	-9.18%	-6.78%	13.42B
BEIJING TONGRENTANG CO., LTD	+0.85%	-4.86%	-31.19%	-55.61%	5.09B
DONG-E-E-JIAO CO., LTD.	-0.84%	-2.23%	+4.50%	-0.04%	5.05B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+4.49%	+0.59%	+6.32%	-30.00%	4.21B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+0.84%	-2.90%	-6.91%	-4.76%	3.69B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-4.39%	-3.50%	-2.12%	+5.41%	3.54B
TASLY PHARMACEUTICAL GROUP CO., LTD	+1.48%	-2.48%	-2.48%	+17.93%	3.48B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+3.37%	+1.21%	-11.98%	-19.36%	2.49B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+0.23%	-3.30%	-3.72%	+46.99%	1.86B
Average	+0.62%	-1.92%	-6.31%	-5.13%	4.28B
Weighted average by Cap.	+0.52%	-2.37%	-7.26%	-9.28%

	2018	2019
Net sales	19.14M 13.73M 11.88M 11.09M 10.17M 1.31B 19.44M 130M 51.08M 655M 51.56M 50.43M 2.17B	22.25M 15.96M 13.81M 12.89M 11.83M 1.52B 22.6M 151M 59.38M 761M 59.94M 58.63M 2.52B
Net income	-36.02M -25.84M -22.36M -20.88M -19.15M -2.46B -36.59M -245M -96.14M -1.23B -97.05M -94.93M -4.08B	-126M -90.34M -78.14M -72.98M -66.94M -8.6B -128M -856M -336M -4.31B -339M -332M -14.25B
Net Debt	-15.55M -11.16M -9.65M -9.01M -8.27M -1.06B -15.8M -106M -41.5M -532M -41.9M -40.98M -1.76B	5.22M 3.75M 3.24M 3.03M 2.78M 357M 5.31M 35.51M 13.94M 179M 14.07M 13.76M 591M

Isodiol International Inc. Stock

Stocks

ISOLF

CA46500L2003

Pharmaceuticals

Valuation: Isodiol International Inc.

Chart: Isodiol International Inc.

Latest news : Isodiol International Inc.

Course Extremes

Managers and Directors: Isodiol International Inc.

Alternative Medicine

Financials

Company Profile